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Introduction: Due to increasing life-span, global ageing rates are rising rapidly and age-
associated diseases are increasing. To ensure that health-span is concomitant with life-span, a 
greater understanding of cellular mechanisms of ageing is important.  
Methods: Telomere-length analysis from a wide range of tissues from weaning, young adult 
and middle-aged (3, 12 and 52 week) male Wistar rats were conducted using Southern-
blotting. Telomere lengths were compared between tissues and ages using regression models 
based on the ratios of longest-to-shortest telomere fragments. 
Results: Robust linear age-dependent telomere attrition was observed in liver; 3wks vs. 
12wks, 3wks vs. 52wks (p<0.01), 12wks vs. 52wks (p<0.05) and heart; 3wks vs. 12wks 
(p<0.05) and 3wks vs. 52wks (p<0.001). More subtle shortening was observed in aorta and 
epididymal fat; 3wks and 12wks vs. 52wks (p<0.001) and in skeletal muscle; 3wks vs. 52wks 
(p<0.05), 12wks vs. 52wks (p<0.01). Young thymus telomeres increased in length (3wks vs. 
12wks) and then shortened between 12wks and 52wks (p<0.001). We also reported disparity 
in telomere shortening within tissues: Telomeres in ageing brain cortex significantly 
shortened; 3wks vs. 52wks (p<0.05), 12wks vs. 52wks (p<0.01). This was not seen in the 
hypothalamic region. Robust step-wise shortening was observed in renal cortex; 3wks vs. 
12wks, 12wks vs. 52wks (p<0.05), and 3 weeks vs. 52 weeks (p<0.001), which was not as 
apparent in renal medulla; 3wks vs. 12wks (p<0.01) and 3wks vs. 52wks (p<0.01). Vastus 
lateralis skeletal muscle demonstrated the shortest telomere length at weaning and underwent 
robust age-associated attrition; 3wks vs. 52wks (p<0.05), 12wks vs. 52wks; (p<0.01). We 
demonstrated that specific tissues exhibit unique telomere attrition profiles which may 
partially explain why certain diseases are more prevalent in aged individuals.  
Discussion/Conclusion: We show wide variation between tissues in vulnerability to the 
ageing process. In the future this may help target potential interventions to improve health-




The World Health Organisation (WHO) estimates that the number of people aged 65 years or 
older in the world will reach 1.5 billion in 2050, compared with 524 million in 2010 [1]. The 
ageing population structure has contributed to observed increases in age-associated diseases 
including cardiovascular disease (CVD), type 2 diabetes (T2D), chronic obstructive 
pulmonary disease (COPD), cancers, dementia, renal dysfunction, non-alcoholic fatty liver 
disease (NAFLD) and obesity. These non-communicable diseases (NCDs) are now 
responsible for 60% of all deaths world-wide [2].  
The increase in the ageing population places an enormous strain on healthcare and social care 
systems throughout the world. Therefore much research is focused on understanding the 
dynamics and underlying molecular mechanisms of the ageing process. Age-associated 
disease prevalence is highly varied. For example, the so-called ‘big four’ NCDs, (CVD, T2D, 
cancers and COPD) make up almost 30% of all NCDs, when expressed in the terms of 
disability-adjusted life year (DALY) score; (a measure of overall disease burden) [2]. A 
major caveat in dissecting out why these four NCDs are the most prevalent of all global 
NCDs, is understanding how both modifiable environmental factors and inherent differences 
in the rate of cellular ageing affects specific tissues. In order to address this question, studies 
of cellular ageing mechanisms in a range of tissues are required.  
Telomeres are guanine-rich repeat DNA sequences (TTAGGG
n
) which are situated at the 
ends of chromosomes and are essential to preserve genomic integrity and stability [3]. The 
extreme terminus of telomeres comprises a guanine-rich 3’ overhang that serves as a template 
for elongation and forms a telomeric `T-loop' which acts to stabilise the telomere. Most 
healthy somatic cells do not express or have low levels of the telomere elongation enzyme, 
telomerase. Telomerase forms a protective ‘cap’ around the telomere, thereby preventing its 
shortening. It comprises of two main components; Tert, a catalytic component with reverse 
transcriptase activity [4] and Terc, which serves as a template for telomeric DNA synthesis 
[5]. Without telomerase, eukaryotic telomeres shorten with each cellular division, due to the 
3’ end replication problem in which full extension of a linear chromosome cannot occur. 
When telomeres of somatic cells reach a critically short length, a conformational change that 
resembles DNA damage occurs and this triggers cell senescence pathways. Senescent cells by 
nature are non-proliferating and are known to contribute to ageing related diseases and 
morbidity [6]. Moreover, several studies have shown that telomere shortening is implicitly 
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associated with cellular ageing [7], disease pathogenesis [8,9] and lifespan [10,11]. Most 
importantly, it is evident that accumulation of critically short telomeres is essential in 
modulating cell senescence and eventual disease pathogenesis [12]. Consequently, we 
developed a telomere length analysis methodology using a telomere restriction fragment 
(TRF) analysis in which the TRF smear was divided into four discreet regions based upon 
molecular weight. This included a very short size range (1.3-4.2kb), intermediate short (4.2-
8.6kb), intermediate long (8.6-48.5kb) and very long (48.5-145kb) telomere lengths [13].   
Previously we have demonstrated telomere shortening in several ageing rat tissues (liver, 
lung, pancreas and whole kidney) which was undetectable using the traditional mean whole 
telomere TRF method of telomere length analysis [13]. Whole brain however, demonstrated 
no change in telomere length with age, using either method [13]. In humans, it is apparent 
that an altered pattern of telomere length dynamics occurs across the life-course. In the first 
years of life, significant age-associated telomere shortening in leucocytes has been reported, 
albeit with high variability reported between individuals [14]. Leucocyte telomere length then 
becomes relatively stable throughout later childhood, preadolescent and adolescent years and 
eventually, telomere shortening rate increases in very old age [15]. Moreover, telomere 
dynamics between tissues may alter between tissues, which could potentially explain why 
different systems in the body are more vulnerable to age-associated changes than others. 
This study therefore aimed to establish if telomere length in a wide range of rat tissues varied 
from an early time-point (weaning) to 52 weeks of age. Secondly, we aimed to establish if 
different tissues exhibited altered rates of age-associated telomere attrition. Within the 
experimental design we performed both TRF length analysis methods and further 
interrogated the size distribution analysis method to maximise its sensitivity. These data may 
identify tissues that are likely to be most vulnerable to external factors that influence the 





Materials and methods 
Male and female Wistar rats (Rattus norvegicus) of breeding age (5-8 weeks of age) were 
purchased from Charles River UK, allowed to acclimatise in Specific Pathogen Free (SPF) 
housing using individually ventilated cages with environmental enrichment and then mated to 
generate an in-house breeding colony. Virgin female offspring weaned from the breeding 
colony were maintained at 22°C, on a controlled 12:12-h light-dark cycle and mated at 
approximately 6 weeks of age (around 240g body weight). Pregnant rats were maintained at 
22°C, on a controlled 12:12-h light-dark cycle, in Specific Pathogen Free (SPF) housing 
using individually ventilated cages with environmental enrichment. Upon detection of a 
vaginal plug dams were maintained on a  20% protein control diet (consisting of 22g/100g 
Casein protein (88g protein/100g) 5.05g/100g mineral and vitamin mixture, 0.22g/100g dI-
methionine, 8g/100g maize starch, 5g/100g cellulose, 4.3g/100g soyabean oil, 55.15g/100g 
glucose) as previously described [16]. Access to the diet and water was provided ad 
libitum. The diet was purchased from Arie Blok (Woerden, The Netherlands). The day of 
birth was recorded as day 1 of postnatal life.  Litters were standardized to 8 pups 48 hours 
after birth, and 4 males in each litter were used in this study. Animals were weaned at 21 days 
of age onto a standardized pellet diet (RM3) (consisting of 15.43% fibre, 1.43% pectin, 9.2% 
hemicellulose, 3.93% cellulose, 1.5% lignin, 33.92% starch, 5.75% sugar, 20.77% assorted 
amino acids, 4.54% assorted fatty acids, 4.65% macro minerals (Special Diet Services, 
Witham, Essex). One male in each litter was culled at 3 weeks of age; one at 12 weeks of age, 
and a third male was culled at 52 weeks of age.  All animals were killed by CO2 asphyxiation 
at approximately 10am after an overnight fast. At post-mortem, heart, aorta, liver, kidney 
cortex, kidney medulla, vastus lateralis (VL) skeletal muscle, liver, epididymal fat, thymus, 
spleen and brain were removed, weighed, and snap frozen in liquid nitrogen and then stored 
at -80ºC until analysis. The brain was dissected into cortex and hypothalamic regions after 
freezing. In all cases, n refers to the number of litters used with the mother as the statistical 
unit and with 1 animal used from each litter at each time point. 
 
Telomere length measurement 
High molecular weight genomic DNA was extracted using a Phenol/Chloroform DNA 
methodology. DNA quantity and purity were determined using a Nanodrop 
spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) [17]. DNA integrity 
was confirmed by agarose gel electrophoresis.  DNA (1.2 µg) was digested by Hinf1 and 
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Rsa1 restriction enzymes at 37
°
C for 2 hours, separated by Pulsed Field Gel Electrophoresis 
(PFGE) and transferred to nylon membranes by Southern Blotting [17, 18]. Standard 
undigested and digested genomic DNA from a 3 week animal was also included on each gel 
to verify digestion efficiency as described previously [17]. Telomere length was measured 
using Telo TAGGG telomere length assays (Roche Diagnostics, Welwyn Garden City, Herts, 
UK). Telomere signals were analyzed using Alpha Ease Software (Alpha Innotech, Exeter, 
Devon, UK). Telomere length was measured using the mean TRF methodology, in which the 
whole telomere smear was quantified. This methodology is detailed in the manufacturers’ 
instructions (Roche Diagnostics, Welwyn Garden City, Herts, UK). This was compared with 
our method of ‘discrete fragment TRF’ telomere length analysis, in which the percentage 
intensity (% telomere length) of the telomeric signal was determined according to 4 
molecular size regions, defined by molecular weight markers [17, 18].  
 
Telomere length analysis 
Telomere length analysis was performed based on telomere restriction fragments (TRF). We 
performed a head to head analysis of methods based on the mean TRF, in which the whole 
telomere smear was quantified, and analysis in which the TRF smear was divided into four 
discreet regions. The four regions were: very short (1.3-4.2kb), intermediate short (4.2-
8.6kb), intermediate long (8.6-48.5kb) and very long (48.5-145kb), and were defined by 
molecular weight markers [13, 17, 18].  
In the initial modelling phase, we compared four different ways of expressing telomere 
length. These were: i) the mean TRF method, (ii) the weighted mean percentage telomere 
fragment length in each sample (i.e. the index of all molecular weight ‘bins’ together), (iii) 
the percentage of telomeres falling within each fragment-length bin separately, and vi) the 
ratio of the percentage of very long/very short telomeres (% L/S). We used linear regression 
models including variables for age and tissue-type to compare the model fit for each method. 
The optimal model was selected using the Akaike Information Criterion (AIC) and lowest 
residual values. Using the ratio of long-to-short telomeres (% L/S) gave the best fit to the data 
overall, particularly when compared with the mean TRF method that is more often used [19]. 
The % L/S method could detect an overall telomere shortening of combined tissues (shown in 




Gene expression of components modulating telomere length 
RNA was extracted using an RNeasy Plus mini kit (Qiagen, Hilden, Germany) following 
manufacturers’ instructions. A DNase digestion step was performed in order to ensure no 
gDNA contamination. RNA (1 µg) was used to synthesize cDNA using oligo-dT primers and 
M-MLV reverse transcriptase (Promega, Southampton, Hants, UK). Gene expression was 
determined using custom designed primers (Sigma, Poole, Dorset, UK) and SYBR Green 
reagents (Applied Biosystems, Warrington, Cheshire, UK). Primer sequences are presented in 
Table 1. Quantification of gene expression was performed using a Step One Plus RT-PCR 
machine (Applied Biosystems, Warrington, Cheshire, UK). Equal efficiency of the reverse 
transcription of RNA from all groups was confirmed through quantification of expression of 
the housekeeping gene Ppia. Expression of Ppia did not differ with respect to age for any 
tissues studied (S1 Table). 
Statistical analysis 
Statistical analysis for telomere length and gene expression was conducted using a 1-way 
ANOVA with age as the independent variable and Duncan’s Post-Hoc testing where 
appropriate, using Statistica, (Statsoft, Palo Alto, CA, USA). Logistic regression and 
correction for multiple hypothesis testing was performed using R, version 3.6.2 (R 
Foundation for Statistical Computing, Vienna, Austria). Where p values are reported, an 
alpha level <0.05 was considered statistically significant. Data are represented as mean ± 




Morphometric analysis of ageing male rat tissues 
As expected, body weights and all tissue weights increased significantly with age (Table 2).  
Overall effect of ageing upon telomere length in male rat tissues 
Telomere length decreased (p<0.001) with age when assessed using the ratio of long-to-short 
telomeres (shown in Fig. 1 a), but this was not apparent using the mean TRF method (shown 
in Fig. 1 b).  
Overall effect of ageing upon telomerase expression 
Although overall Tert1 and Terc expression numerically decreased with age, this was 
statistically non-significant (Tert1; p=0.24) (Terc; p=0.22) (shown in Fig. 1 c and Fig. 1 d).  
The effect of tissue type upon telomere length in male rats at weaning 
At weaning, telomere length varied by tissue type: The ratio of long-to-short telomeres was 
highest (approximately 1.0 % L/S) in the kidney (1.14 ± 0.2 % L/S), the liver (1.01 ± 0.04 % 
L/S), and thymus (0.93 ± 0.08 % L/S) (shown in Fig. 2 a). This was followed by telomere 
lengths in the spleen (0.73 ± 0.13 % L/S), heart (0.61 ± 0.07 % L/S) and aorta (0.68 ± 0.05 % 
L/S), the epididymal fat pad (0.48 ± 0.03 % L/S), brain cortex (0.44 ± 0.02 % L/S) and brain 
hypothalamus (0.54 ± 0.03 % L/S) (shown in Fig. 2 a). Telomeres from vastus lateralis (VL) 
skeletal muscle were shortest (0.36 ± 0.02 % L/S) (shown in Fig. 2 a). 
Telomerase components at weaning 
Different tissues had a range of telomerase expression levels at weaning. Detectable levels of 
Tert1 and Terc was observed in the liver of weanling rats, with lower but still detectable 
expression of telomerase observed in the kidney, which was also the case for Tert1 
expression in brain cortex and hypothalamus (shown in Fig. 2 b and Fig. 2 c). Heart and aorta 
were on the margins of detection for telomerase expression. Tert1 and Terc were not 
detectable in epididymal fat (shown in Fig. 2 b and Fig. 2 c). The immunological tissues 
(thymus and spleen) had extremely high expression of both Tert1 and Terc (shown in Fig. 2 b 
and Fig. 2 c) at weaning. 
Comparison of age-associated telomere length dynamics  
9 
 
Significant age-associated telomere attrition was observed in the classical insulin sensitive 
tissues (except brain and kidney): Liver (3 vs. 12 weeks; p<0.01, 12 vs. 52 weeks; p<0.05, 3 
vs. 52 weeks; p<0.01), VL (3 vs. 52 weeks; p<0.05, 12 vs. 52 weeks; p<0.01) and the 
epididymal fat pad (3 and 12 weeks vs. 52 weeks; p<0.001) (shown in Fig. 3 a).  
Telomeres from both regions of the kidney shortened significantly with age: Kidney cortex (3 
weeks vs. 12 weeks; p<0.05, 12 vs. 52 weeks; p<0.05 and 3 weeks vs. 52 weeks; p<0.001) 
(shown in Fig. 3 b) and kidney medulla (3 vs. 12 weeks and 3 vs. 52 weeks, p<0.01) (shown 
in Fig. 3 b).  
In the cardiovascular system, significant age-associated telomere shortening was observed in 
both cardiac (3 vs. 12 weeks; p<0.05 and vs. 52 weeks, p<0.001) (shown in Figure 3 c) and 
aortic tissue (3 and 12 weeks vs. 52 weeks; p<0.001) (shown in Fig. 3 c).  
Immunological tissues demonstrated a unique pattern of telomere length dynamics. In the 
thymus, telomere length elongated significantly in the young tissue then between 12 and 52 
weeks decreased significantly back to levels observed at 3 weeks (3 vs. 12 weeks and vs. 52 
weeks; p<0.001) (shown in Fig. 3 d). In the spleen, no significant age-associated telomere 
shortening was observed (shown in Fig. 3 d).  
The brain cortex demonstrated shorter telomeres at 52 weeks compared to 3 weeks (p<0.05) 
and compared to 12 weeks (p<0.01) (shown in Fig. 3 e), however no change in telomere 




Improved understanding of mechanisms that modulate ageing may ultimately lead to 
extension of health-span. Telomere length is a robust marker of cellular ageing and disease 
pathogenesis [7, 11], and is often considered a proxy for biological ageing.  
We demonstrate significant shortening of telomeres in ageing tissues that was not detected 
using the mean TRF method. Our mathematical modelling suggests that measurement of 
discrete areas of the telomere is the optimum method of telomere length measurement. These 
findings are particularly important, given that the loss of a few hundred base pairs from short 
telomeres is pivotal to cellular ageing [11,12]. Such losses may go undetected by traditional 
mean TRF analysis as the TRFs with few telomeric repeats seem to be obscured by the strong 
signal from other TRFs with long telomeres.  
Weaning telomere length & telomerase expression 
Telomeres at weaning were longest in thymus, liver and the kidney. In the thymus, 
preservation of telomere length is essential to preserve immunological function and T-cell 
lineage [20] and may be related to the high expression of telomerase in young thymic tissue, 
as evidenced in this study and in previous work [20,21]. In the rat, longer hepatic telomeres at 
weaning may also relate in part to the marginally telomerase positive nature of this tissue 
[22]. This is recapitulated by the observed low, but detectable expression of Tert1 and Terc 
mRNA. The liver is a regenerative organ and telomerase expression has been linked with the 
tissue’s regenerative properties [23,24]. Therefore rat hepatic telomeres may start longer in 
early postnatal life to prepare for the potential increased cell division later in life when the 
liver may need to regenerate. Male rat kidneys are known to deteriorate relatively quickly 
with age and have increased susceptibility to age-associated end stage renal damage, with 
renal disease the most common cause of mortality in ageing male rats [25]. Therefore long 
renal telomeres at weaning may be a compensatory attempt to preserve telomere length and 
cellular integrity for as long as possible. Preservation of renal telomere length at weaning 
may be related to the detectable levels of Tert1 and Terc expression. In contrast VL telomeres 
at weaning demonstrated the smallest proportion of long telomeres suggesting that telomeres 
in this type of skeletal muscle are already much shorter than in other tissues in early life. 
Tissue-specific telomere length                                     
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The rates and patterns of age-associated changes in telomere length differed between tissues.  
All classical insulin sensitive tissues, with the exception of the brain underwent significant 
telomere shortening with age: The liver underwent a significant step-wise shortening 
(behaving like a classical somatic cell population). Accelerated hepatic telomere shortening is 
associated with the progression of liver disease including non-alcoholic fatty liver disease, 
fibrosis, [26] cirrhosis and hepatocellular carcinoma [27]. The epididymal fat maintained 
longer telomeres at 3 and 12 weeks of age, which then drops off significantly at 52 weeks of 
age.  In VL, the robust age-associated telomere shortening combined with the fact that this 
tissue started with the shortest telomeres at weaning, may have particular detrimental 
implications for the aetiology of glucose intolerance, insulin sensitivity and T2D [28-30].  
Subtle differences in the dynamics of age-associated telomere shortening were apparent 
between regions of the kidney. The renal cortex underwent robust step-wise shortening with 
significant telomere attrition observed throughout the ageing process. However, the renal 
medulla underwent a more graded telomere attrition which occurred only between young (3 
to 12 weeks of age) tissue.  Previously, we demonstrated that the cortex region of rat kidney 
shortens faster than the medulla [31], which is also reflective of that observed in the human 
[32]. This may potentially be due to differences in mitochondrial density. Mammalian 
proximal renal tubules contain an abundance of large mitochondria dependent on oxidative 
rather than anaerobic metabolism [33]. In contrast, the cells within the inner medulla are 
known to have a far lower mitochondrial content compared with the cortical cells. 
Mitochondria are known contributors to reactive oxygen species (ROS) generation [34] 
which preferentially damages telomeric DNA sequences, due to guanine-rich residues within 
the telomere [35]. The renal cortex may be more liable to generate ROS via oxidative 
metabolism than the more anaerobic medullary cells and therefore will have telomeres which 
shorten faster than those found in the medulla.  
We also observed an age-associated shortening of cardiac telomeres, suggesting that this 
tissue is behaving like a classic somatic cell type. Aortic telomeres also shorten with age, 
however this began after 12 weeks, with no significant shortening observed in young tissue. 
Cardiac tissue is extremely metabolically active and cardiomyocytes have a high 
mitochondrial mass by comparison to other less metabolically active tissues [36].  
Conversely, myocytes from smooth muscle (aorta) have relatively few mitochondria (22% of 
the estimated number in cardiac muscle) [37]. Therefore, it is plausible that the increased 
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mitochondrial mass in cardiac muscle is a key modulator of the accelerated telomere 
shortening observed in the heart.  
Between 3 and 12 weeks of age, the ratio of long-to-short telomeres in the thymus increased. 
This pattern was unique to this tissue and may be necessary for development of 
immunological function [20]. We previously reported that telomere length in the brain did not 
change in the ageing male rat [13], which has also been reported in human brain tissue [38]. 
We also observed that age-associated telomere length attrition was much less pronounced in 
the brain tissue overall, compared to other tissues. Interestingly, when the cortex and 
hypothalamic regions were analysed separately, telomere shortening was detected in the 
cortex which was not observed in the hypothalamus. It has been demonstrated that cortical 
brain regions are more sensitive to development of Alzheimer’s disease [39]. Therefore, the 
observed accelerated telomere shortening in the brain cortex may be a driving factor in its 
susceptibility to age-associated neurodegeneration which specifically affect cortical regions 
of the brain.  
 
In conclusion, our findings are consistent with factors relating to telomere length dynamics 
being pivotal in cell senescence and that the observed patterns vary considerably by tissue 
type, [40]. Telomere length in early postnatal life (weaning) could be regarded as an 
important set-point in determining the fate of the tissue in later life, particularly if this is 
combined with a high rate of telomere length attrition, as demonstrated in skeletal muscle. 
This is particularly important given recent evidence suggesting that the rate of telomere 
attrition is a powerful predictor of lifespan [11]. However rapid telomere attrition may occur 
irrespective of the initial ‘set-point’ of telomere length, as demonstrated in cardiac tissue and 
in the kidney in which telomeres were not short at weaning, however they underwent robust 
rates of age-associated telomere attrition. High mitochondrial density and therefore oxidative 
stress are perhaps pivotal mechanisms for these findings. Our findings may partially explain 
why CVD and T2D are common NCDs, however we acknowledge that we cannot claim 
causality based upon these findings alone. We also demonstrated that the function of the 
tissue may also be a factor in determining telomere dynamics: The urinary tract, CNS, and 
immunological tissues demonstrate markedly different age-associated telomere dynamics, 
potentially driven by the differences in cell proliferation and/or different mitochondrial 
densities, yet this association needs to be fully elucidated. A greater understanding of 
telomere dynamics could potentially help determine which tissues are more vulnerable to the 
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ageing process and help to target any potential interventions. We also demonstrated that our 
discrete TRF telomere fragment analysis, was the more sensitive and reliable approach for 
analysing telomere length in a wide range of ageing rat tissues, compared with the mean TRF 
method in a comprehensive range of rat tissues. 
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Figure Legends  
Fig. 1: The effect of ageing upon overall telomere length measured by Southern Blotting and 
telomerase expression by RT-PCR in rats at 3, 12 and 52 weeks of age using a) Discrete 
fragment TRF method or b) Mean TRF method. c) Tert1 expression and d) Terc expression. 
N=8 per group; ± SEM. 
Fig 2: a) Telomere length measured by Southern Blotting, b) Tert1 expression and c) Terc 
expression measured by RT-PCR in weanling male rats. N=8 per group; ± SEM. 
Fig. 3: The effect of individual tissue types upon telomere length measured by Southern 
Blotting in: a) Insulin sensitive, b) Urinary system, c) Cardiovascular system, d) 














































Tert1 5’ CTGGCAGGTATACGGCTTTC 3’ 5’ CTTTAAGAAGCGGCGCTCA 3’ 92 
 
Terc 5’ CCGCCGTGAAGAGCTAGT 3’ 5’ TCAGGGACCAGTTCCGTTAC 3’ 97 
 
























Table 2 Morphometric analysis of ageing male rats 
 
Tissue 3 weeks 12 weeks 52 weeks 
 
Body weight (g) 49 ± 2 *** 475 ± 15 $$$ 956 ± 41 & 
 
Aorta (mg) 11 ± 1 *** 63 ± 11 $$$ 85 ± 7 &&& 
 
Heart (mg) 37 ± 2 *** 1436 ± 85 $$$ 2055 ± 164 &&& 
 
Kidney (L) (mg) 30 ± 1 *** 1800 ± 63 $$$ 2533 ± 163 &&& 
 
Liver (mg) 178 ± 7 *** 17345 ± 758 $$$ 28608 ± 2041 &&& 
 
Thymus (mg) 12 ± 1 *** 753 ± 55 $$$ 1197 ± 96 &&& 
 
Spleen (mg) 26 ± 4 *** 1129.0 ± 67 $$$ 1735 ± 116 &&& 
 
Brain (mg) 144 ± 2 *** 2050 ± 34 $$$ 2181 ± 38 && 
 
VL (mg) 45 ± 11 *** 4115 ± 145 $$$ 6691 ± 373 &&& 
 










3 weeks 12 weeks 52 weeks p value 
Liver 
 
36370 ± 2804 34551 ± 3580 36968 ± 1956 0.81 
Heart 
 
27888 ± 1150 29805 ± 3595 26814 ± 3033 0.71 
Aorta 
 
87980 ± 9303 88429 ± 10767 76261 ± 8227 0.59 
Kidney cortex 
 
104751 ± 9170 82542 ± 8386 105054 ± 8587 0.17 
Kidney Medulla 
 
107712 ± 12932 96378 ± 8215 124858 ± 12688 0.25 
Thymus 
 
53154 ± 5671 48906 ± 9007 46596 ± 6901 0.83 
Spleen 
 
16721 ± 3628 15330 ± 1772 19905 ± 3056 0.51 
 
